Abstract
The major function of microtubule-associated protein tau is to promote microtubule assembly in the central nervous system. However, aggregation of abnormally phosphorylated tau is a hallmark of tauopathies. Although the molecular mechanisms of conformational transitions and assembling of tau molecules into amyloid fibril remain largely unknown, several factors have been shown to promote tau aggregation, including mutations, polyanions, phosphorylation, and interactions with other proteins. 14-3-3 proteins are a family of highly conserved, multifunctional proteins that are mainly expressed in the central nervous system. Being a scaffolding protein, 14-3-3 proteins interact with tau and regulate tau phosphorylation by bridging tau with various protein kinases. 14-3-3 proteins also directly regulate tau aggregation via specific and non-specific interactions with tau. In this review, we summarize recent advances in characterization of tau conformation and tau/14-3-3 interaction. We discuss the connection between 14-3-3 binding and tau aggregation with a special emphasis on the regulatory role of 14-3-3 on tau conformation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, Lin R, Paudel HK (2003) 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 278:12722–12728. https://doi.org/10.1074/jbc.M211491200
Aitken A (1995) 14-3-3 proteins on the MAP. Trends Biochem Sci 20:95–97
Aitken A (2006) 14-3-3 proteins: a historic overview. Semin Cancer Biol 16:162–172. https://doi.org/10.1016/j.semcancer.2006.03.005
Akoury E, Mukrasch MD, Biernat J, Tepper K, Ozenne V, Mandelkow E, Blackledge M, Zweckstetter M (2016) Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer. Protein Sci 25:1010–1020. https://doi.org/10.1002/pro.2911
Andrei SA, Meijer FA, Neves JF, Brunsveld L, Landrieu I, Ottmann C, Milroy LG (2018) Inhibition of 14-3-3/tau by hybrid small-molecule peptides operating via two different binding modes. ACS Chem Neurosci 9:2639–2654. https://doi.org/10.1021/acschemneuro.8b00118
Avila J, Jimenez JS, Sayas CL, Bolos M, Zabala JC, Rivas G, Hernandez F (2016) Tau structures. Front Aging Neurosci 8:262. https://doi.org/10.3389/fnagi.2016.00262
Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosci 8:663–672. https://doi.org/10.1038/nrn2194
Baxter HC, Fraser JR, Liu WG, Forster JL, Clokie S, Steinacker P, Otto M, Bahn E, Wiltfang J, Aitken A (2002) Specific 14-3-3 isoform detection and immunolocalization in prion diseases. Biochem Soc Trans 30:387–391. https://doi.org/10.1042/bst0300387
Berg D, Holzmann C, Riess O (2003) 14-3-3 proteins in the nervous system. Nat Rev Neurosci 4:752–762. https://doi.org/10.1038/nrn1197
von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E (2000) Assembly of τ protein into Alzheimer paired helical filaments depends on a local sequence motif (306VQIVYK311) forming β structure. Proc Natl Acad Sci U S A 97:5129–5134
von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem 276:48165–48174. https://doi.org/10.1074/jbc.M105196200
Berry RW, Abraha A, Lagalwar S, LaPointe N, Gamblin TC, Cryns VL, Binder LI (2003) Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. Biochemistry 42:8325–8331. https://doi.org/10.1021/bi027348m
Cau Y, Valensin D, Mori M, Draghi S, Botta M (2018) Structure, function, involvement in diseases and targeting of 14-3-3 proteins: an update. Curr Med Chem 25:5–21. https://doi.org/10.2174/0929867324666170426095015
Chen J, Kanai Y, Cowan NJ, Hirokawa N (1992) Projection domains of MAP 2 and tau determine spacings between microtubules in dendrites and axons. Nature 360:674–677. https://doi.org/10.1038/360674a0
Chen H, Liu S, Li S, Chen J, Ni J, Liu Q (2018) Blocking the thiol at cysteine-322 destabilizes tau protein and prevents its oligomer formation. ACS Chem Neurosci 9:1560–1565. https://doi.org/10.1021/acschemneuro.8b00003
Chirita CN, Congdon EE, Yin H, Kuret J (2005) Triggers of full-length tau aggregation: a role for partially folded intermediates. Biochemistry 44:5862–5872. https://doi.org/10.1021/bi0500123
Chong FP, Ng KY, Koh RY, Chye SM (2018) Tau proteins and tauopathies in Alzheimer’s disease. Cell Mol Neurobiol 38:965–980. https://doi.org/10.1007/s10571-017-0574-1
Chun J, Kwon T, Lee EJ, Kim CH, Han YS, Hong SK, Hyun S, Kang SS (2004) 14-3-3 protein mediates phosphorylation of microtubule-associated protein tau by serum- and glucocorticoid-induced protein kinase 1. Mol Cell 18:360–368
Congdon EE, Kim S, Bonchak J, Songrug T, Matzavinos A, Kuret J (2008) Nucleation-dependent tau filament formation: the importance of dimerization and an estimation of elementary rate constants. J Biol Chem 283:13806–13816. https://doi.org/10.1074/jbc.M800247200
Cornell B, Toyo-Oka K (2017) 14-3-3 proteins in brain development: neurogenesis, neuronal migration and neuromorphogenesis. Front Mol Neurosci 10:318. https://doi.org/10.3389/fnmol.2017.00318
Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG, Ficarra G, Federico M et al (2009) Identification of protein clusters predictive of response to chemotherapy in breast cancer patients. J Proteome Res 8:4916–4933. https://doi.org/10.1021/pr900239h
Dai JG, Murakami K (2003) Constitutively and autonomously active protein kinase C associated with 14-3-3 zeta in the rodent brain. J Neurochem 84:23–34
Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, Greenberg ME (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6:41–51
Dosztanyi Z (2018) Prediction of protein disorder based on IUPred. Protein Sci 27:331–340. https://doi.org/10.1002/pro.3334
Elbaum-Garfinkle S, Rhoades E (2012) Identification of an aggregation-prone structure of tau. J Am Chem Soc 134:16607–16613. https://doi.org/10.1021/ja305206m
Falcon B, Cavallini A, Angers R, Glover S, Murray TK, Barnham L, Jackson S, O’Neill MJ, Isaacs AM, Hutton ML et al (2015) Conformation determines the seeding potencies of native and recombinant tau aggregates. J Biol Chem 290:1049–1065. https://doi.org/10.1074/jbc.M114.589309
Fantl WJ, Muslin AJ, Kikuchi A, Martin JA, MacNicol AM, Gross RW, Williams LT (1994) Activation of Raf-1 by 14-3-3 proteins. Nature 371:612–614. https://doi.org/10.1038/371612a0
Fitzpatrick AWP, Falcon B, He S, Murzin AG, Murshudov G, Garringer HJ, Crowther RA, Ghetti B, Goedert M, Scheres SHW (2017) Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature 547:185–190. https://doi.org/10.1038/nature23002
Foote M, Zhou Y (2012) 14-3-3 proteins in neurological disorders. Int J Biochem Mol Biol 3:152–164
Friedhoff P, von Bergen M, Mandelkow EM, Davies P, Mandelkow E (1998) A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A 95:15712–15717
Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40:617–647. https://doi.org/10.1146/annurev.pharmtox.40.1.617
Furukawa Y, Ikuta N, Omata S, Yamauchi T, Isobe T, Ichimura T (1993) Demonstration of the phosphorylation-dependent interaction of tryptophan hydroxylase with the 14-3-3 protein. Biochem Biophys Res Commun 194:144–149. https://doi.org/10.1006/bbrc.1993.1796
Goedert M, Spillantini MG (2017) Propagation of tau aggregates. Mol Brain 10:18. https://doi.org/10.1186/s13041-017-0298-7
Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8:393–399
Goux WJ, Kopplin L, Nguyen AD, Leak K, Rutkofsky M, Shanmuganandam VD, Sharma D, Inouye H, Kirschner DA (2004) The formation of straight and twisted filaments from short tau peptides. J Biol Chem 279:26868–26875. https://doi.org/10.1074/jbc.M402379200
Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein τ (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913–4917
Hashiguchi M, Sobue K, Paudel HK (2000) 14-3-3zeta is an effector of tau protein phosphorylation. J Biol Chem 275:25247–25254. https://doi.org/10.1074/jbc.M003738200
Hernandez F, Cuadros R, Avila J (2004) Zeta 14-3-3 protein favours the formation of human tau fibrillar polymers. Neurosci Lett 357:143–146. https://doi.org/10.1016/j.neulet.2003.12.049
Himmelstein DS, Ward SM, Lancia JK, Patterson KR, Binder LI (2012) Tau as a therapeutic target in neurodegenerative disease. Pharmacol Ther 136:8–22. https://doi.org/10.1016/j.pharmthera.2012.07.001
Holehouse AS, Das RK, Ahad JN, Richardson MO, Pappu RV (2017) CIDER: resources to analyze sequence-ensemble relationships of intrinsically disordered proteins. Biophys J 112:16–21. https://doi.org/10.1016/j.bpj.2016.11.3200
Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG (1996) The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 335:924–930. https://doi.org/10.1056/NEJM199609263351303
Iqbal K, Liu F, Gong CX (2016) Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 12:15–27. https://doi.org/10.1038/nrneurol.2015.225
Jeganathan S, von Bergen M, Brutlach H, Steinhoff HJ, Mandelkow E (2006) Global hairpin folding of tau in solution. Biochemistry 45:2283–2293. https://doi.org/10.1021/bi0521543
Jeganathan S, Hascher A, Chinnathambi S, Biernat J, Mandelkow EM, Mandelkow E (2008) Proline-directed pseudo-phosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation. J Biol Chem 283:32066–32076. https://doi.org/10.1074/jbc.M805300200
Jicha GA, O’Donnell A, Weaver C, Angeletti R, Davies P (1999) Hierarchical phosphorylation of recombinant tau by the paired-helical filament-associated protein kinase is dependent on cyclic AMP-dependent protein kinase. J Neurochem 72:214–224
Joo Y, Schumacher B, Landrieu I, Bartel M, Smet-Nocca C, Jang A, Choi HS, Jeon NL, Chang KA, Kim HS, Ottmann C, Suh YH (2015) Involvement of 14-3-3 in tubulin instability and impaired axon development is mediated by tau. FASEB J 29:4133–4144. https://doi.org/10.1096/fj.14-265009
Jouanne M, Rault S, Voisin-Chiret AS (2017) Tau protein aggregation in Alzheimer’s disease: an attractive target for the development of novel therapeutic agents. Eur J Med Chem 139:153–167. https://doi.org/10.1016/j.ejmech.2017.07.070
Kadavath H, Jaremko M, Jaremko L, Biernat J, Mandelkow E, Zweckstetter M (2015) Folding of the tau protein on microtubules. Angew Chem Int Ed Eng 54:10347–10351. https://doi.org/10.1002/anie.201501714
Kadavath H, Cabrales Fontela Y, Jaremko M, Jaremko L, Overkamp K, Biernat J, Mandelkow E, Zweckstetter M (2018) The binding mode of a tau peptide with tubulin. Angew Chem Int Ed Eng 57:3246–3250. https://doi.org/10.1002/anie.201712089
Kellogg EH, Hejab NMA, Poepsel S, Downing KH, DiMaio F, Nogales E (2018) Near-atomic model of microtubule-tau interactions. Science 360:1242–1246. https://doi.org/10.1126/science.aat1780
King ME, Ahuja V, Binder LI, Kuret J (1999) Ligand-dependent tau filament formation: implications for Alzheimer’s disease progression. Biochemistry 38:14851–14859
Kopke E, Tung YC, Shaikh S, Alonso AC, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem 268:24374–24384
Kosik KS, Joachim CL, Selkoe DJ (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83:4044–4048
Kumar S, Tepper K, Kaniyappan S, Biernat J, Wegmann S, Mandelkow EM, Muller DJ, Mandelkow E (2014) Stages and conformations of the tau repeat domain during aggregation and its effect on neuronal toxicity. J Biol Chem 289:20318–20332. https://doi.org/10.1074/jbc.M114.554725
Lasagna-Reeves CA, Castillo-Carranza DL, Sengupta U, Sarmiento J, Troncoso J, Jackson GR, Kayed R (2012) Identification of oligomers at early stages of tau aggregation in Alzheimer’s disease. FASEB J 26:1946–1959. https://doi.org/10.1096/fj.11-199851
Layfield R, Fergusson J, Aitken A, Lowe J, Landon M, Mayer RJ (1996) Neurofibrillary tangles of Alzheimer’s disease brains contain 14-3-3 proteins. Neurosci Lett 209:57–60
Leal MF, Calcagno DQ, Demachki S, Assumpcao PP, Chammas R, Burbano RR, Smith Mde A (2012) Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol 18:1531–1537. https://doi.org/10.3748/wjg.v18.i13.1531
Lee G, Leugers CJ (2012) Tau and tauopathies. Prog Mol Biol Transl Sci 107:263–293. https://doi.org/10.1016/B978-0-12-385883-2.00004-7
Li C, Gotz J (2017) Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov 16:863–883. https://doi.org/10.1038/nrd.2017.155
Li T, Paudel HK (2016) 14-3-3zeta mediates tau aggregation in human neuroblastoma M17 cells. PLoS One 11:e0160635. https://doi.org/10.1371/journal.pone.0160635
Li X, Romero P, Rani M, Dunker AK, Obradovic Z (1999) Predicting protein disorder for N-, C-, and internal regions. Genome Inform 10:30–40
Liu F, Li B, Tung EJ, Grundke-Iqbal I, Iqbal K, Gong CX (2007) Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation. Eur J Neurosci 26:3429–3436. https://doi.org/10.1111/j.1460-9568.2007.05955.x
Liu Y, Tian RF, Li YM, Liu WP, Cao L, Yang XL, Cao WD, Zhang X (2010) The expression of seven 14-3-3 isoforms in human meningioma. Brain Res 1336:98–102. https://doi.org/10.1016/j.brainres.2010.04.009
Maiza A, Chantepie S, Vera C, Fifre A, Huynh MB, Stettler O, Ouidja MO, Papy-Garcia D (2018) The role of heparan sulfates in protein aggregation and their potential impact on neurodegeneration. FEBS Lett 592:3806–3818. https://doi.org/10.1002/1873-3468.13082
Mancini M, Corradi V, Petta S, Barbieri E, Manetti F, Botta M, Santucci MA (2011) A new nonpeptidic inhibitor of 14-3-3 induces apoptotic cell death in chronic myeloid leukemia sensitive or resistant to imatinib. J Pharmacol Exp Ther 336:596–604. https://doi.org/10.1124/jpet.110.172536
Manger LH, Foote AK, Wood SL, Holden MR, Heylman KD, Margittai M, Goldsmith RH (2017) Revealing conformational variants of solution-phase intrinsically disordered tau protein at the single-molecule level. Angew Chem Int Ed Eng 56:15584–15588. https://doi.org/10.1002/anie.201708242
Martin H, Rostas J, Patel Y, Aitken A (1994) Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies. J Neurochem 63:2259–2265
Matta A, Siu KWM, Ralhan R (2012) 14-3-3 zeta as novel molecular target for cancer therapy. Expert Opin Ther Targets 16:515–523. https://doi.org/10.1517/14728222.2012.668185
Mhawech P (2005) 14-3-3 proteins--an update. Cell Res 15:228–236. https://doi.org/10.1038/sj.cr.7290291
Milroy LG, Bartel M, Henen MA, Leysen S, Adriaans JM, Brunsveld L, Landrieu I, Ottmann C (2015) Stabilizer-guided inhibition of protein-protein interactions. Angew Chem Int Ed Eng 54:15720–15724. https://doi.org/10.1002/anie.201507976
Mukrasch MD, Biernat J, von Bergen M, Griesinger C, Mandelkow E, Zweckstetter M (2005) Sites of tau important for aggregation populate {beta}-structure and bind to microtubules and polyanions. J Biol Chem 280:24978–24986. https://doi.org/10.1074/jbc.M501565200
Mukrasch MD, Markwick P, Biernat J, Bergen M, Bernado P, Griesinger C, Mandelkow E, Zweckstetter M, Blackledge M (2007a) Highly populated turn conformations in natively unfolded tau protein identified from residual dipolar couplings and molecular simulation. J Am Chem Soc 129:5235–5243. https://doi.org/10.1021/ja0690159
Mukrasch MD, von Bergen M, Biernat J, Fischer D, Griesinger C, Mandelkow E, Zweckstetter M (2007b) The “jaws” of the tau-microtubule interaction. J Biol Chem 282:12230–12239. https://doi.org/10.1074/jbc.M607159200
Mukrasch MD, Bibow S, Korukottu J, Jeganathan S, Biernat J, Griesinger C, Mandelkow E, Zweckstetter M (2009) Structural polymorphism of 441-residue tau at single residue resolution. PLoS Biol 7:e34. https://doi.org/10.1371/journal.pbio.1000034
Muslin AJ, Tanner JW, Allen PM, Shaw AS (1996) Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889–897
Mylonas E, Hascher A, Bernado P, Blackledge M, Mandelkow E, Svergun DI (2008) Domain conformation of tau protein studied by solution small-angle X-ray scattering. Biochemistry 47:10345–10353. https://doi.org/10.1021/bi800900d
Neal CL, Yu D (2010) 14-3-3zeta as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets 14:1343–1354. https://doi.org/10.1517/14728222.2010.531011
Nizynski B, Dzwolak W, Nieznanski K (2017) Amyloidogenesis of tau protein. Protein Sci 26:2126–2150. https://doi.org/10.1002/pro.3275
Ottmann C (2013) Small-molecule modulators of 14-3-3 protein-protein interactions. Bioorg Med Chem 21:4058–4062. https://doi.org/10.1016/j.bmc.2012.11.028
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277:1501–1505
Petri MK, Koch P, Stenzinger A, Kuchelmeister K, Nestler U, Paradowska A, Steger K, Brobeil A, Viard M, Wimmer M (2011) PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3beta and PTP1B in situ. Histol Histopathol 26:1531–1543. https://doi.org/10.14670/HH-26.1531
Pozuelo-Rubio M (2012) 14-3-3 proteins are pegulators of autophagy. Cells 1:754–773. https://doi.org/10.3390/cells1040754
Preuss U, Biernat J, Mandelkow EM, Mandelkow E (1997) The ‘jaws’ model of tau-microtubule interaction examined in CHO cells. J Cell Sci 110(Pt 6):789–800
Qureshi HY, Han D, MacDonald R, Paudel HK (2013a) Overexpression of 14-3-3ζ promotes tau phosphorylation at Ser262 and accelerates proteosomal degradation of synaptophysin in rat primary hippocampal neurons. PLoS One 8:e84615. https://doi.org/10.1371/journal.pone.0084615
Qureshi HY, Li T, MacDonald R, Cho CM, Leclerc N, Paudel HK (2013b) Interaction of 14-3-3 zeta with microtubule-associated protein tau within Alzheimer’s disease neurofibrillary tangles. Biochemistry 52:6445–6455. https://doi.org/10.1021/bi400442d
Ramachandran G, Udgaonkar JB (2011) Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by tau protein. J Biol Chem 286:38948–38959. https://doi.org/10.1074/jbc.M111.271874
Ramachandran G, Udgaonkar JB (2013) Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer’s disease and the tauopathies. Biochemistry 52:4107–4126. https://doi.org/10.1021/bi400209z
Romero P, Obradovic Z, Dunker AK (1997) Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Inform 8:110–124
Rosenberg KJ, Ross JL, Feinstein HE, Feinstein SC, Israelachvili J (2008) Complementary dimerization of microtubule-associated tau protein: implications for microtubule bundling and tau-mediated pathogenesis. Proc Natl Acad Sci U S A 105:7445–7450. https://doi.org/10.1073/pnas.0802036105
Rosenquist M, Sehnke P, Ferl RJ, Sommarin M, Larsson C (2000) Evolution of the 14-3-3 protein family: does the large number of isoforms in multicellular organisms reflect functional specificity? J Mol Evol 51:446–458
Sadik G, Tanaka T, Kato K, Yamamori H, Nessa BN, Morihara T, Takeda M (2009a) Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation. J Neurochem 108:33–43. https://doi.org/10.1111/j.1471-4159.2008.05716.x
Sadik G, Tanaka T, Kato K, Yanagi K, Kudo T, Takeda M (2009b) Differential interaction and aggregation of 3-repeat and 4-repeat tau isoforms with 14-3-3zeta protein. Biochem Biophys Res Commun 383:37–41. https://doi.org/10.1016/j.bbrc.2009.03.107
Sahara N, Maeda S, Murayama M, Suzuki T, Dohmae N, Yen SH, Takashima A (2007) Assembly of two distinct dimers and higher-order oligomers from full-length tau. Eur J Neurosci 25:3020–3029. https://doi.org/10.1111/j.1460-9568.2007.05555.x
Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T (2010) Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Investig 90:1637–1644. https://doi.org/10.1038/labinvest.2009.68
Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38:3549–3558. https://doi.org/10.1021/bi981874p
Schwalbe M, Ozenne V, Bibow S, Jaremko M, Jaremko L, Gajda M, Jensen MR, Biernat J, Becker S, Mandelkow E, Zweckstetter M, Blackledge M (2014) Predictive atomic resolution descriptions of intrinsically disordered hTau40 and alpha-synuclein in solution from NMR and small angle scattering. Structure 22:238–249. https://doi.org/10.1016/j.str.2013.10.020
Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E (1994) Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for β-structure. J Biol Chem 269:24290–24297
Seidler PM, Boyer DR, Rodriguez JA, Sawaya MR, Cascio D, Murray K, Gonen T, Eisenberg DS (2018) Structure-based inhibitors of tau aggregation. Nat Chem 10:170–176. https://doi.org/10.1038/nchem.2889
Shimada T, Fournier AE, Yamagata K (2013) Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int 2013:564534. https://doi.org/10.1155/2013/564534
Sibille N, Sillen A, Leroy A, Wieruszeski JM, Mulloy B, Landrieu I, Lippens G (2006) Structural impact of heparin binding to full-length tau as studied by NMR spectroscopy. Biochemistry 45:12560–12572. https://doi.org/10.1021/bi060964o
Skoulakis EM, Davis RL (1998) 14-3-3 proteins in neuronal development and function. Mol Neurobiol 16:269–284. https://doi.org/10.1007/BF02741386
Sluchanko NN (2018) Association of multiple phosphorylated proteins with the 14-3-3 regulatory hubs: problems and perspectives. J Mol Biol 430:20–26. https://doi.org/10.1016/j.jmb.2017.11.010
Sluchanko NN, Gusev NB (2011) Probable participation of 14-3-3 in tau protein oligomerization and aggregation. J Alzheimers Dis 27:467–476. https://doi.org/10.3233/JAD-2011-110692
Sluchanko NN, Seit-Nebi AS, Gusev NB (2009a) Phosphorylation of more than one site is required for tight interaction of human tau protein with 14-3-3zeta. FEBS Lett 583:2739–2742. https://doi.org/10.1016/j.febslet.2009.07.043
Sluchanko NN, Seit-Nebi AS, Gusev NB (2009b) Effect of phosphorylation on interaction of human tau protein with 14-3-3zeta. Biochem Biophys Res Commun 379:990–994. https://doi.org/10.1016/j.bbrc.2008.12.164
Sluchanko NN, Sudnitsyna MV, Chernik IS, Seit-Nebi AS, Gusev NB (2011a) Phosphomimicking mutations of human 14-3-3zeta affect its interaction with tau protein and small heat shock protein HspB6. Arch Biochem Biophys 506:24–34. https://doi.org/10.1016/j.abb.2010.11.003
Sluchanko NN, Sudnitsyna MV, Seit-Nebi AS, Antson AA, Gusev NB (2011b) Properties of the monomeric form of human 14-3-3zeta protein and its interaction with tau and HspB6. Biochemistry 50:9797–9808. https://doi.org/10.1021/bi201374s
Song J, Park KA, Lee WT, Lee JE (2014) Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer’s disease. Int J Mol Sci 15:2119–2129. https://doi.org/10.3390/ijms15022119
Soulie C, Nicole A, Delacourte A, Ceballos-Picot I (2004) Examination of stress-related genes in human temporal versus occipital cortex in the course of neurodegeneration: involvement of 14-3-3 zeta in this dynamic process. Neurosci Lett 365:1–5. https://doi.org/10.1016/j.neulet.2004.03.090
Strang KH, Croft CL, Sorrentino ZA, Chakrabarty P, Golde TE, Giasson BI (2018) Distinct differences in prion-like seeding and aggregation between tau protein variants provide mechanistic insights into tauopathies. J Biol Chem 293:2408–2421. https://doi.org/10.1074/jbc.M117.815357
Takahashi M, Kawamura A, Kato N, Nishi T, Hamachi I, Ohkanda J (2012) Phosphopeptide-dependent labeling of 14-3-3 zeta proteins by fusicoccin-based fluorescent probes. Angew Chem Int Ed Eng 51:509–512. https://doi.org/10.1002/anie.201106995
Takeda S, Wegmann S, Cho H, DeVos SL, Commins C, Roe AD, Nicholls SB, Carlson GA, Pitstick R, Nobuhara CK et al (2015) Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain. Nat Commun 6:8490. https://doi.org/10.1038/ncomms9490
Tzivion G, Avruch J (2002) 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J Biol Chem 277:3061–3064. https://doi.org/10.1074/jbc.R100059200
Uhart M, Bustos DM (2013) Human 14-3-3 paralogs differences uncovered by cross-talk of phosphorylation and lysine acetylation. PLoS One 8:e55703. https://doi.org/10.1371/journal.pone.0055703
Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T, Ikeda K, Takasaki M (2004) 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer’s disease. Acta Neuropathol 108:279–286. https://doi.org/10.1007/s00401-004-0885-4
Wang JZ, Grundke-Iqbal I, Iqbal K (2007) Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur J Neurosci 25:59–68. https://doi.org/10.1111/j.1460-9568.2006.05226.x
Wegmann S, Scholer J, Bippes CA, Mandelkow E, Muller DJ (2011) Competing interactions stabilize pro- and anti-aggregant conformations of human tau. J Biol Chem 286:20512–20524. https://doi.org/10.1074/jbc.M111.237875
Wegmann S, Medalsy ID, Mandelkow E, Muller DJ (2013) The fuzzy coat of pathological human tau fibrils is a two-layered polyelectrolyte brush. Proc Natl Acad Sci U S A 110:E313–E321. https://doi.org/10.1073/pnas.1212100110
Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci U S A 72:1858–1862
Wischik CM, Novak M, Thogersen HC, Edwards PC, Runswick MJ, Jakes R, Walker JE, Milstein C, Roth M, Klug A (1988a) Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85:4506–4510
Wischik CM, Novak M, Edwards PC, Klug A, Tichelaar W, Crowther RA (1988b) Structural characterization of the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A 85:4884–4888
Wischik CM, Harrington CR, Storey JM (2014) Tau-aggregation inhibitor therapy for Alzheimer’s disease. Biochem Pharmacol 88:529–539. https://doi.org/10.1016/j.bcp.2013.12.008
Wood JG, Mirra SS, Pollock NJ, Binder LI (1986) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (τ). Proc Natl Acad Sci U S A 83:4040–4043
Wu LN, Wei XW, Fan Y, Miao JN, Wang LL, Zhang Y, Wu D, Yuan ZW (2013) Altered expression of 14-3-3ζ protein in spinal cords of rat fetuses with spina bifida aperta. PLoS One 8:e70457. https://doi.org/10.1371/journal.pone.0070457
Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Laupretre N, Cuadrado Corrales N et al (2000) Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 55:811–815
Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87:619–628
Zhang L, Chen J, Fu H (1999) Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci U S A 96:8511–8515
Zhu HL, Fernandez C, Fan JB, Shewmaker F, Chen J, Minton AP, Liang Y (2010) Quantitative characterization of heparin binding to tau protein: implication for inducer-mediated tau filament formation. J Biol Chem 285:3592–3599. https://doi.org/10.1074/jbc.M109.035691
Zhu S, Shala A, Bezginov A, Sljoka A, Audette G, Wilson DJ (2015) Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble. PLoS One 10:e0120416. https://doi.org/10.1371/journal.pone.0120416
Funding
This work was financially supported by the National Natural Science Foundation of China (grant 21603121 to Y.H.) and funding from the Hubei University of Technology (M.G., Y.H., and Z.S.).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, Y., Chen, X., Yao, Z. et al. 14-3-3/Tau Interaction and Tau Amyloidogenesis. J Mol Neurosci 68, 620–630 (2019). https://doi.org/10.1007/s12031-019-01325-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-019-01325-9